iTeos Therapeutics, Inc.

NASDAQ:ITOS

8.97 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -112.64296.652214.521-38.033-22.454-18.057
Depreciation & Amortization 0.8980.8030.6030.5350.6110.505
Deferred Income Tax -3.03600-1.265-1.0190.13
Stock Based Compensation 27.02121.56113.7944.2920.8090.112
Change In Working Capital -8.799-228.491284.219.33-1.082-1.856
Accounts Receivables -2.3853.988-3.3445.033-4.8541.087
Inventory 2.385-3.9883.344-5.0334.854-1.274
Accounts Payables 3.0362.7612.281.677-0.155-0.133
Other Working Capital -11.835-231.252281.937.653-0.927-1.536
Other Non Cash Items -7.198-1.7180.012-0.035-0.010.069
Operating Cash Flow -103.756-111.193513.14-25.176-23.145-19.097
Investing Activities:
Investments In Property Plant And Equipment -2.966-0.938-1.181-0.356-0.721-0.226
Acquisitions Net 000000
Purchases Of Investments -290.541-445.0040000
Sales Maturities Of Investments 366.26400000
Other Investing Activites -0.099-0.12-0.061-0.021-0.205-0.073
Investing Cash Flow 72.658-446.062-1.242-0.377-0.926-0.299
Financing Activities:
Debt Repayment 000000
Common Stock Issued 1.1130.9252.943213.6622.47423.33
Common Stock Repurchased 000-0.3320-0.226
Dividends Paid 000000
Other Financing Activities 1.1131.0590.716127.0110.06523.734
Financing Cash Flow 1.1131.9843.659340.33922.53923.508
Other Information:
Effect Of Forex Changes On Cash -3.602-8.526-3.1761.678-0.532-0.875
Net Change In Cash -33.587-563.797512.381316.464-2.0643.237
Cash At End Of Period 251.451285.038848.835336.45419.9922.054